ARCHIVES

Phase III Trial: Panobinostat Increases PFS by Four Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI extends Deadline for Three RFAs

July 9, 1999

CCOPS Unhappy With NCI Policy Limiting Their Participation In Early Phase 2 Clinical Trials

November 11, 1983

$1 Million Gift to Duke Funds Urologic Research Center.

November 24, 2000

In Brief: Budget Timetable Puts Pressure On Congress To Complete Appropriations Before Oct. 1

January 30, 1976

Cancer Meetings For May, June, Future

April 27, 1990

Conference Explores Hype And Hope In Communicating Science News

May 15, 1998